Wendy Young joins MPM Capital as Executive Partner, having spent 25 years in biopharma, and most recently 15 years at Genentech, where she led small-molecule drug discovery. At MPM, she will use her years of chemistry and drug discovery experience to advise on investments and support creation of new company ventures.